Results 241 to 250 of about 55,609 (295)

Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban.

Journal of the American Medical Association (JAMA)
Importance Diltiazem, a commonly prescribed ventricular rate-control medication for patients with atrial fibrillation, inhibits apixaban and rivaroxaban elimination, possibly causing overanticoagulation.
Wayne A. Ray, Cecilia P Chung, C. M. Stein, Walter E. Smalley, Eli Zimmerman, William D. Dupont, Adriana M. Hung, J. Daugherty, A. Dickson, Katherine T. Murray   +9 more
semanticscholar   +1 more source

Organogels, hydrogels and bigels as transdermal delivery systems for diltiazem hydrochloride

Asian Journal of Pharmaceutical Sciences, 2013
M. Ibrahim, Salma A. Hafez, Mahmoud M. Mahdy   +2 more
exaly   +2 more sources

Diltiazem

Reactions Weekly, 2021
  +4 more sources

Diltiazem

Reactions Weekly, 1993
  +5 more sources

Diltiazem

Reactions Weekly, 2023
  +4 more sources

Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA

JACC: Cardiovascular Imaging, 2022
Tijn P J Jansen, Regina E Konst, Steven Teerenstra   +2 more
exaly  

Diltiazem

Reactions Weekly, 1992
openaire   +2 more sources

Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P‐gp Inhibition

Phytotherapy Research, 2017
B. Athukuri, P. Neerati
semanticscholar   +1 more source

Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation

Clinical drug investigation, 2018
M. Jandali
semanticscholar   +1 more source

Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes

Archives of pharmacal research, 2018
J. Byeon, Yun-Jeong Lee, Young-hoon Kim, Se-Hyung Kim, Choong-Min Lee, J. Bae, C. Jang, Seok-Yong Lee, Chang-ik Choi   +8 more
semanticscholar   +1 more source